A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients.

Clinical trial NCT06512116 · RECRUITING

Trial details

NCT number: NCT06512116
Sponsor: Shanghai Institute Of Biological Products
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-07-23
Primary completion: 2026-07-30
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.